Reduced VDAC1 protects against alzheimer's disease, mitochondria, and synaptic deficiencies

Journal of Alzheimer's Disease

Volumn 37, Issue 4, 2013, Pages 679-690

  Manczak, Maria ^a   Sheiko, Tatiana ^b   Craigen, William J ^b   Reddy, P Hemachandra ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Amyloid ; knockout mouse model; mitochondrial function; oxidative stress; real time reverse transcriptase PCR; voltage dependent anion channel 1

Indexed keywords

ADENOSINE TRIPHOSPHATE; CYTOCHROME C OXIDASE; FREE RADICAL; GUANOSINE TRIPHOSPHATASE; HEXOKINASE 1; HEXOKINASE 2; MESSENGER RNA; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG; VOLTAGE DEPENDENT ANION CHANNEL 1;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRP1 GENE; ENZYME ACTIVITY; FIS1 GENE; FUSION GENE; GENE; LEARNING; LEARNING DISORDER; LIPID PEROXIDATION; MFN 2 GENE; MFN1 GENE; MITOCHONDRION; MOUSE; NERVE CELL PLASTICITY; NEUROGRANIN GENE; NONHUMAN; POSTSYNAPTIC DENSITY PROTEIN 95 GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNAPSE; SYNAPSIN I GENE; SYNAPTIC POTENTIAL; SYNAPTOBREVIN 1 GENE; SYNAPTOBREVIN 2 GENE; SYNAPTOPHYSIN GENE; UPREGULATION;

AMYLOID-Β; KNOCKOUT MOUSE MODEL; MITOCHONDRIAL FUNCTION; OXIDATIVE STRESS; REAL-TIME REVERSE TRANSCRIPTASE PCR; VOLTAGE-DEPENDENT ANION CHANNEL 1;

ALZHEIMER DISEASE; ANIMALS; DOWN-REGULATION; MICE; MICE, KNOCKOUT; MITOCHONDRIA; SYNAPSES; VOLTAGE-DEPENDENT ANION CHANNEL 1;

EID: 84892710629     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-130761     Document Type: Article

References (52)

1. Selkoe DJ (2001) Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 81, 741-766.
2. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
3. LaFerla FM, Green KN, Oddo S (2007) Intracellular amyloidbeta in Alzheimer's disease. Nat Rev Neurosci 8, 499-509.
4. Reddy PH, Beal MF (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: Implications for cognitive decline in aging and Alzheimer's disease. Trends Mol Med 14, 45-53.
5. Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, Manczak M (2012) Abnormal mitochondrial dynamics and synaptic degeneration as early events in Alzheimer's disease: Implications to mitochondria-targeted antioxidant therapeutics. Biochim Biophys Acta 1822, 639-649.
6. Swerdlow RH (2011) Brain aging, Alzheimer's disease, and mitochondria. Biochim Biophys Acta 1812, 1630-1639.
7. Reddy PH, McWeeney S, Park BS, Manczak M, Gutala RV, Partovi D, Jung Y, Yau V, Searles R, Mori M, Quinn J (2004) Gene expression profiles of transcripts in amyloid precursor protein transgenic mice: Up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 13, 1225-1240.
8. Manczak M, Park BS, Jung Y, Reddy PH (2004) Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: Implications for early mitochondrial dysfunction and oxidative damage. Neuromolecular Med 5, 147-162.
9. Du H, Guo L, Yan S, Sosunov AA, McKhann GM, Yan SS (2010) Early deficits in synaptic mitochondria in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A 107, 18670-18675.
10. Calkins MJ, Manczak M, Mao P, Shirendeb UP, Reddy PH (2011) Impaired mitochondrial biogenesis, defective axonal transport of mitochondria, abnormal mitochondrial dynamics and synaptic degeneration in a mouse model of Alzheimer's disease. Hum Mol Genet 20, 4515-4529.
11. Zhu X, Perry G, Smith MA, Wang X (2013) Abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease. J Alzheimers Dis 33, S253-S562.
12. Devi L, Prabhu BM, Galati DF, Avadhani NG, Anandatheerthavarada HK (2006) Accumulation of amyloid precursor protein in the mitochondrial import channels of human Alzheimer's disease brain is associated with mitochondrial dysfunction. J Neurosci 26, 9057-9068.
13. Parker WD Jr, Filley CM, Parks JK (1990) Cytochrome oxidase deficiency in Alzheimer's disease. Neurology 40, 1302-1303.
14. Maurer I, Zierz S, Moller HJ (2000) A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol Aging 21, 455-462.
15. Smith MA, Perry G, Richey PL, Sayre LM, Anderson VE, Beal MF, Kowall N (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
16. Wang J, Xiong S, Xie C, Markesber WR, Lovell MA (2005) Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 93, 953-962.
17. Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA (2007) Proteomics analysis of the Alzheimer's disease hippocampal proteome. J Alzheimers Dis 11, 153-164.
18. Manczak M, Anekonda TS, Henson E, Park BS, Quinn J, Reddy PH (2006) Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: Implications for free radical generation and oxidative damage in disease progression. Hum Mol Genet 15, 1437-1449.
19. Manczak M, Calkins MJ, Reddy PH (2011) Impaired mitochondrial dynamics and abnormal interaction of amyloid beta with mitochondrial protein Drp1 in neurons from patients with Alzheimer's disease: Implications for neuronal damage. Hum Mol Genet 20, 2495-2509.
20. Manczak M, Reddy PH (2012) Abnormal interaction of VDAC1 with amyloid beta and phosphorylated tau in Alzheimer's disease neurons cause mitochondrial dysfunction. Hum Mol Genet 21, 5131-5146.
21. Yao J, Irwin RW, Zhao L, Nilsen J, Hamilton RT, Brinton RD (2009) Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A 106, 14670-14675.
22. Caspersen C,Wang CN,Yao J, SosunovA, Chen X, Lustbader JW,XuHW, Stern D, McKhann G,Yan S.S. (2005) Mitochondrial Abeta: A potential focal point for neuronal metabolic dysfunction in Alzheimer's disease. FASEB J 19, 2040-2041.
23. Devi L, OhnoM(2012) Mitochondrial dysfunction and accumulation of the -secretase-cleaved C-terminal fragment of APP in Alzheimer's disease transgenic mice. Neurobiol Dis 45, 417-424.
24. Crouch IJ, BlakeR, Duce JA, Ciccotosto CD, Li QX, Barnham KJ, Curtain CC, Cherny RA, Cappai R, Dyrks T, Masters CL, Trounce IA (2005) Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloidbeta1- 42. J Neurosci 25, 672-679.
25. Wang X, Su B, Siedlak SL, Moreira PI, Fujioka H, Wang Y, Casadesus G, Zhu X (2008) Amyloid-beta overproduction causes abnormal mitochondrial dynamics via differential modulation of mitochondrial fission/fusion proteins. Proc Natl Acad Sci U S A 105, 19318-19323.
26. Wang X, Su B, Lee HG, Li X, Perry G, Smith MA, Zhu X (2009) Impaired balance of mitochondrial fission and fusion in Alzheimer's disease. J Neurosci 29, 9090-9103.
27. Reddy PH, Reddy TP (2011) Mitochondria as a therapeutic target for aging and neurodegenerative diseases. Curr Alzheimer Res 8, 393-409.
28. Hodge T, Colombini M, Regulation of metabolite flux through voltage-gating of VDAC channels. J Membr Biol 157, 271- 279.
29. Rostovtseva T, Colombini M. VDAC channels mediate and gate the flow of ATP: Implications for the regulation of mitochondrial function. Biophys J 72, 1954-1962.
30. Baines CP, Kaiser RA, Sheiko T, Craigen WJ, Molkentin JD (2007) Voltage-dependent anion channels are dispensable for mitochondrial-dependent cell death. Nat Cell Biol 9, 550-555.
31. ColombiniM(2012)VDACstructure, selectivity, and dynamics. Biochim Biophys Acta 1818, 1457-1465.
32. Du H, Guo L, Fang F, Chen D, Sosunov AA, McKhann GM, Yan Y, Wang C, Zhang H, Molkentin JD, Gunn-Moore FJ, Vonsattel JP, Arancio O, Chen JX,Yan SD(2008) Cyclophilin D deficiency attenuates mitochondrial and neuronal perturbation andameliorates learning and memory in Alzheimer's disease. Nat Med 14, 1097-1105.
33. Du H, Guo L, Wu X, Sosunov AA, McKhann GM, Chen JX, Yan SS (2013) CyclophilinDdeficiency rescuesA-impaired PKA/CREB signaling and alleviates synaptic degeneration. Biochim Biophys Acta, doi: Pii: S0925-4439(13)00078-1.
34. Guo L, Du H, Yan S, Wu X, McKhann GM, Chen JX, Yan SS (2013) CyclophilinDdeficiency rescues axonal mitochondrial transport in Alzheimer's neurons. PLoS One 8, e54914.
35. Raghavan A, Sheiko T, Graham BH, Craigen WJ (2012) Voltage-dependant anion channels: Novel insights into isoform function through genetic models. Biochim Biophys Acta 1818, 1477-1485.
36. Shimizu S, Narita M, Tsujimoto Y (1999) Bcl-2 family proteins regulate the release of apoptogenic cytochrome c by the mitochondrial channel VDAC. Nature 399, 483-487.
37. Weeber EJ, Levy M, Sampson MJ, Anflous K, Armstrong DL, Brown SE, Sweatt JD, Craigen WJ (2002) The role of mitochondrial porins and the permeability transition pore in learning and synaptic plasticity. J Biol Chem 277, 18891- 18897.
38. ReddyPH(2013) Is the mitochondrial outermembrane protein VDAC1 therapeutic target for Alzheimer's disease Biochim Biophys Acta 1832, 67-75.
39. Gutala RV, Reddy PH (2004) The use of real-time PCR analysis in a gene expression study of Alzheimer's disease post-mortem brains. J Neurosci Methods 132, 101-107.
40. Reddy TP, Manczak M, Calkins MJ, Mao P, Reddy AP, Shirendeb U, Park B, Reddy PH (2011) Toxicity of neurons treated with herbicides and neuroprotection by mitochondriatargeted antioxidant SS31. Int J Environ Res Public Health 8, 203-221.
41. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, Reddy PH (2010) Mitochondriatargeted antioxidants protect against amyloid-beta toxicity in Alzheimer's disease neurons. J Alzheimers Dis 20, S609- S631.
42. Drew B, Leeuwenburgh C (2003) Method for measuring ATP production in isolated mitochondria: ATP production in brain and liver mitochondria of Fischer-344 rats with age and caloric restriction. Am J Physiol Regul Integr Comp Physiol 285, R1259-R1267.
43. Hall ED, Bosken JM (2009) Measurement of oxygen radicals and lipid peroxidation in neural tissues. Curr Protoc Neurosci Chapter 7, Unit 7.17.1-51.
44. Shirendeb UP, Calkins MJ,Manczak M, Anekonda V, Dufour B, McBride JL, Mao P, Reddy PH (2012) Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease. Hum Mol Genet 21, 406-420.
45. Manczak M, Reddy PH (2012) Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: Implications for mitochondrial dysfunction and neuronal damage. Hum Mol Genet 21, 2538-2547.
46. Israelson A, Arbel N, Da Cruz S, Ilieva H, Yamanaka K, Shoshan-BarmatzV, ClevelandDW(2010) Misfolded mutant SOD1 directly inhibits VDAC1 conductance in a mouse model of inherited ALS. Neuron 67, 575-587.
47. Shoshan-Barmatz V, Keinan N, Zaid H (2008) Uncovering the role of VDAC in the regulation of cell life and death. J Bioenerg Biomembr 40, 183-191.
48. Shoshan-Barmatz V, De Pinto V, Zweckstetter M, Raviv Z, Keinan N, Arbel N. VDAC, a multi-functional mitochondrial protein regulating cell life and death. Mol Aspects Med 31, 227-285.
49. Abu-Hamad S, Zaid H, Israelson A, Nahon E, Shoshan- Barmatz V (2008) Hexokinase-I protection against apoptotic cell death is mediated via interaction with the voltagedependent anion channel-1: Mapping the site of binding. J Biol Chem 283, 13482-13490.
50. Ghosh T, Pandey N, Maitra A, Brahmachari SK, Pillai B (2007) A role for voltage-dependent anion channel Vdac1 in polyglutamine-mediated neuronal cell death. PLoS One 2, e1170.
51. Zaid H, Abu-Hamad S, Israelson A, Nathan I, Shoshan- Barmatz V (2005) The voltage-dependent anion channel-1 modulates apoptotic cell death. Cell Death Differ 12, 751-760.
52. Shirendeb U, Reddy AP, Manczak M, Calkins MJ, Mao P, TagleDA, ReddyPH(2011) Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: Implications for selective neuronal damage. Hum Mol Genet 20, 1438-1455.